{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T17:00:33Z","timestamp":1744736433905},"reference-count":45,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.cjca.2014.08.012","type":"journal-article","created":{"date-parts":[[2014,8,23]],"date-time":"2014-08-23T13:47:14Z","timestamp":1408801634000},"page":"1607-1612","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Brain Natriuretic Peptide for Prevention of Contrast-Induced Nephropathy After Percutaneous Coronary Intervention or Coronary Angiography"],"prefix":"10.1016","volume":"30","author":[{"given":"Jin-Ming","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Nan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Han","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-Guang","family":"Zu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ming","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2014.08.012_bib1","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.amjcard.2009.02.039","article-title":"Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention","volume":"103","author":"Jabara","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2014.08.012_bib2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.rcl.2009.06.001","article-title":"Contrast-induced acute kidney injury (CIAKI)","volume":"47","author":"Solomon","year":"2009","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.cjca.2014.08.012_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjcard.2004.08.056","article-title":"Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables","volume":"95","author":"Dangas","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2014.08.012_bib4","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jacc.2004.07.043","article-title":"Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction","volume":"44","author":"Marenzi","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.08.012_bib5","first-page":"119","article-title":"Economic burden of contrast-induced nephropathy: implications for prevention strategies","volume":"10","author":"Subramanian","year":"2007","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.cjca.2014.08.012_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ccd.10534","article-title":"Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine","volume":"59","author":"Lindsay","year":"2003","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2014.08.012_bib7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.rcl.2009.06.002","article-title":"Contrast-induced nephropathy after intravenous administration: fact or fiction?","volume":"47","author":"Katzberg","year":"2009","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.cjca.2014.08.012_bib8","first-page":"149","article-title":"Recommendations for prevention of contrast-media induced nepropathy","volume":"25","author":"Arkouche","year":"2004","journal-title":"Nephrologie"},{"key":"10.1016\/j.cjca.2014.08.012_bib9","first-page":"1393","article-title":"A\u00a0simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation","volume":"44","author":"Mehran","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.08.012_bib10","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s00330-011-2225-0","article-title":"Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines","volume":"21","author":"Stacul","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cjca.2014.08.012_bib11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cjca.2013.12.029","article-title":"Lower blood vitamin D levels are associated with an increased incidence of contrast-induced nephropathy in patients undergoing coronary angiography","volume":"30","author":"Sahin","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2014.08.012_bib12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1148\/radiology.204.2.9240511","article-title":"Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity","volume":"204","author":"Katzberg","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.cjca.2014.08.012_bib13","doi-asserted-by":"crossref","first-page":"14K","DOI":"10.1016\/j.amjcard.2006.01.020","article-title":"Pathophysiology of contrast-induced nephropathy","volume":"98","author":"Tumlin","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2014.08.012_bib14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/02841850802050762","article-title":"Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention","volume":"49","author":"Nyman","year":"2008","journal-title":"Acta Radiol"},{"key":"10.1016\/j.cjca.2014.08.012_bib15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa021833","article-title":"Nephrotoxic effects in high-risk patients undergoing angiography","volume":"348","author":"Aspelin","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.08.012_bib16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.rli.0000229742.54589.7b","article-title":"Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects","volume":"41","author":"Solomon","year":"2006","journal-title":"Invest Radiol"},{"key":"10.1016\/j.cjca.2014.08.012_bib17","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/CIRCULATIONAHA.106.687152","article-title":"Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies","volume":"115","author":"Briguori","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.08.012_bib18","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCULATIONAHA.111.030759","article-title":"Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury","volume":"124","author":"Briguori","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.08.012_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jcin.2011.08.017","article-title":"Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial","volume":"5","author":"Marenzi","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2014.08.012_bib20","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/ndt\/gfh261","article-title":"Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury","volume":"19","author":"Drager","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cjca.2014.08.012_bib21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000326269","article-title":"Statins for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis","volume":"33","author":"Zhang","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.cjca.2014.08.012_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ndt\/15.1.43","article-title":"Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? PGE1 Study Group","volume":"15","author":"Koch","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cjca.2014.08.012_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pharmthera.2004.04.004","article-title":"Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance","volume":"102","author":"Abassi","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cjca.2014.08.012_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1161\/01.RES.0000117070.86556.9F","article-title":"B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation","volume":"94","author":"Kapoun","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2014.08.012_bib25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM200007273430403","article-title":"Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group","volume":"343","author":"Colucci","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.08.012_bib26","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1517\/13543784.13.6.643","article-title":"Recent advances in natriuretic peptides in congestive heart failure","volume":"13","author":"Boerrigter","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.cjca.2014.08.012_bib27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1472-8206.2005.00336.x","article-title":"Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology","volume":"19","author":"Houben","year":"2005","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.cjca.2014.08.012_bib28","doi-asserted-by":"crossref","first-page":"R1093","DOI":"10.1152\/ajpregu.00682.2004","article-title":"Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure","volume":"288","author":"Chen","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.cjca.2014.08.012_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jclinane.2004.03.006","article-title":"Effects of atrial natriuretic peptide at a low dose on water and electrolyte metabolism during general anesthesia","volume":"17","author":"Koda","year":"2005","journal-title":"J\u00a0Clin Anesth"},{"key":"10.1016\/j.cjca.2014.08.012_bib30","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/01.CCM.0000128560.57111.CD","article-title":"Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial","volume":"32","author":"Sward","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cjca.2014.08.012_bib31","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0002-9343(89)90437-3","article-title":"Dosing of contrast material to prevent contrast nephropathy in patients with renal disease","volume":"86","author":"Cigarroa","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.cjca.2014.08.012_bib32","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3109\/02841851.2010.486804","article-title":"B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention","volume":"51","author":"Zhang","year":"2010","journal-title":"Acta Radiol"},{"key":"10.1016\/j.cjca.2014.08.012_bib33","first-page":"669","article-title":"The use of recombinant human B-type natriuretic peptide for the protection of cardiac and renal functions in heart failure patients with acute anterior myocardial infarction in peri-operative period of primary percutaneous coronary intervention","volume":"22","author":"Zhang","year":"2010","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"10.1016\/j.cjca.2014.08.012_bib34","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cpcardiol.2004.07.002","article-title":"The natriuretic peptides in cardiovascular medicine","volume":"29","author":"Munagala","year":"2004","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cjca.2014.08.012_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00380-009-1171-0","article-title":"Low-dose nesiritide improves renal function in heart failure patients following acute myocardial infarction","volume":"25","author":"Zhao","year":"2010","journal-title":"Heart Vessels"},{"key":"10.1016\/j.cjca.2014.08.012_bib36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/clc.20750","article-title":"Long-term outcome of patients treated with prophylactic nesiritide for the prevention of acute kidney injury following cardiovascular surgery","volume":"33","author":"Lingegowda","year":"2010","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cjca.2014.08.012_bib37","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1524-4733.2010.00710.x","article-title":"Projecting the effect of nesiritide on dialysis and hospital mortality in cardiac surgery patients","volume":"13","author":"He","year":"2010","journal-title":"Value Health"},{"key":"10.1016\/j.cjca.2014.08.012_bib38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1751-7133.2011.00272.x","article-title":"The effect of nesiritide on renal function and other clinical parameters in patients with decompensated heart failure and preserved ejection fraction","volume":"18","author":"Kelesidis","year":"2012","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.cjca.2014.08.012_bib39","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0735-1097(01)01172-X","article-title":"Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects","volume":"37","author":"Brunner-La Rocca","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.08.012_bib40","first-page":"F863","article-title":"Effects of synthetic atrial natriuretic factor on renal function and renin release","volume":"247","author":"Burnett","year":"1984","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cjca.2014.08.012_bib41","first-page":"91","article-title":"Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man","volume":"76","author":"Holmes","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjca.2014.08.012_bib42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/01.RES.70.2.241","article-title":"Atrial and brain natriuretic peptides inhibit the endothelin-1 secretory response to angiotensin II in porcine aorta","volume":"70","author":"Kohno","year":"1992","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2014.08.012_bib43","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1172\/JCI115228","article-title":"Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells","volume":"87","author":"Kohno","year":"1991","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cjca.2014.08.012_bib44","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1440-1681.1992.tb00507.x","article-title":"Effects of arginine vasopressin, angiotensin II and endothelin-1 on the release of brain natriuretic peptide in\u00a0vivo and in\u00a0vitro","volume":"19","author":"Horio","year":"1992","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.cjca.2014.08.012_bib45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1568016053544309","article-title":"Natriuretic peptide family: new aspects","volume":"3","author":"Cea","year":"2005","journal-title":"Curr Med Chem Cardiovasc Hematol Agents"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X1401280X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X1401280X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T07:09:09Z","timestamp":1565766549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X1401280X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0828282X1401280X"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2014.08.012","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain Natriuretic Peptide for Prevention of Contrast-Induced Nephropathy After Percutaneous Coronary Intervention or Coronary Angiography","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2014.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}